TOWA Pharmaceutical Co Ltd TWAPF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- $24.35–24.35
- 52-Week Range
- $24.35–24.35
- Bid/Ask
- $16.97 / $35.85
- Market Cap
- $1.20 Bil
- Volume/Avg
- 187 / 187
Key Statistics
- Price/Earnings (Normalized)
- 7.85
- Price/Sales
- 0.83
- Dividend Yield (Trailing)
- 0.87%
- Dividend Yield (Forward)
- 0.01%
- Total Yield
- 0.87%
Company Profile
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 5,135
- Website
- http://www.towayakuhin.co.jp
Comparables
Valuation
|
Metric
|
TWAPF
|
4569
|
1SKF401E
|
|---|---|---|---|
Price/Earnings (Normalized) | 7.85 | 26.71 | — |
Price/Book Value | 1.06 | 0.82 | — |
Price/Sales | 0.83 | 0.86 | — |
Price/Cash Flow | 4.88 | 11.16 | — |
Price/Earnings
TWAPF
4569
1SKF401E
Financial Strength
|
Metric
|
TWAPF
|
4569
|
1SKF401E
|
|---|---|---|---|
Quick Ratio | 1.17 | 1.33 | 5.90 |
Current Ratio | 2.77 | 2.53 | 5.90 |
Interest Coverage | 22.74 | 94.05 | — |
Quick Ratio
TWAPF
4569
1SKF401E
Profitability
|
Metric
|
TWAPF
|
4569
|
1SKF401E
|
|---|---|---|---|
Return on Assets (Normalized) | 4.58% | 3.16% | 11.93% |
Return on Equity (Normalized) | 12.37% | 4.40% | 14.50% |
Return on Invested Capital (Normalized) | 5.69% | 3.57% | 14.48% |
Return on Assets
TWAPF
4569
1SKF401E
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Kfzwtzxlsk | Szmnpv | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Rvnglcjml | Plsk | $68.3 Bil | |
HLN
| Haleon PLC ADR | Xgcypyzt | Prx | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Dwtstppw | Vlvr | $14.5 Bil | |
VTRS
| Viatris Inc | Gkjwfqnt | Vcgf | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lttjxzj | Shbt | $11.9 Bil | |
CTLT
| Catalent Inc | Ctpyypvmz | Vxljrwl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Hltctntp | Gbzds | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Twfvvxkq | Ljwm | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Yktvysls | Vfjyxrx | $3.5 Bil |